Last reviewed · How we verify

NCT05684471

SFIB vs Anterior QLB in Total Hip Arthroplasty

Completed NA Last updated 8 May 2024
What this trial tests

NA trial testing Ultrasound Guided Suprainguinal Fascia iliaca Block in Pain in 65 participants. Completed in 7 May 2024.

Timeline
18 January 2023
Primary endpoint
7 May 2024
7 May 2024

Quick facts

Lead sponsorSamsun University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment65
Start date18 January 2023
Primary completion7 May 2024
Estimated completion7 May 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Samsun University

Who can join

Adults 18 to 75, any sex, with Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Quadratus lumborum block (QLB) is a facial plane block defined to provide analgesia from T7-L3 dermatomes. There are articles reporting that it is an effective analgesic method in hip surgeries. Suprainguinal fascia iliaca block (SIFIB) also blocks components of the lumbar plexus and provides effective analgesia in hip surgeries. The investigators aim to compare the effectiveness of QLB and SIFIB in patients undergoing primary total hip arthroplasty (THA).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain

Currently open trials in the same condition.

Other Samsun University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05684471.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing